Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol ointment for cutaneous warts
IRCT20170818035762N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of calcitriol in verruca (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Treatment response, Reduction in wart number and lesion size and 1 more. Started Jan 2020; status: completed.
02
Drugs
calcitriol
03
Conditions
verruca
Beyond the preview
Go deeper on IRCT20170818035762N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170818035762N2.